13595 studies found for:    Canada
Show Display Options
Rank Status Study
1 Completed Nexium Dyspepsia/AST
Conditions: Gastrointestinal Disease;   Signs and Symptoms, Digestive;   Dyspepsia
Intervention: Drug: Esomeprazole
2 Completed ISIS 5132 in Treating Patients With Metastatic or Recurrent Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Drug: ISIS 5132
3 Active, not recruiting The 36-month Extension to Follow up Sub Study
Conditions: Postphlebitic Syndrome;   Post-Thrombotic Syndrome;   Deep Vein Thrombosis
4 Recruiting A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Condition: Ulcerative Colitis
5 Completed Radiation Therapy and Chemotherapy in Treating Patients With Hodgkin's Disease
Condition: Hodgkin Lymphoma
Interventions: Biological: bleomycin sulfate;   Drug: dacarbazine;   Drug: doxorubicin hydrochloride;   Drug: vinblastine;   Radiation: radiation therapy
6 Completed EVEREST: Efficacy of Vasopressin Antagonism in hEart failuRE: Outcome Study With Tolvaptan
Condition: Congestive Heart Failure
Intervention: Drug: Tolvaptan
7 Completed A Study of RO4607381 in Stable Coronary Heart Disease Patients With Recent Acute Coronary Syndrome
Condition: Coronary Heart Disease
Interventions: Drug: dalcetrapib;   Drug: Evidence-based medical care for Acute Coronary Syndrome;   Drug: Placebo
8 Completed
Has Results
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Conditions: Heart Failure;   Anemia;   Cardiovascular Disease;   Ventricular Dysfunction;   Congestive Heart Failure
Interventions: Drug: Darbepoetin alfa;   Drug: Placebo
9 Completed
Has Results
Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD): The HERMES Study (BY217/M2-125)
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: Roflumilast;   Drug: Placebo
10 Recruiting Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Psoriasis
Condition: Psoriasis
11 Completed S9900: Surgery With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: carboplatin;   Drug: paclitaxel;   Procedure: conventional surgery
12 Completed Marimastat Following Chemotherapy in Treating Patients With Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: marimastat;   Drug: Placebo
13 Completed
Has Results
Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In Men
Conditions: Neoplasms, Prostate;   Prostate Cancer
Interventions: Drug: Dutasteride;   Drug: Matching placebo
14 Completed Zyban as an Effective Smoking Cessation Aid for Patients Following an Acute Coronary Syndrome: The ZESCA Trial
Conditions: Acute Coronary Syndrome;   Myocardial Infarction;   Smoking
Interventions: Drug: Bupropion HCl ER;   Drug: Placebo
15 Completed
Has Results
Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women
Condition: Osteoporosis
Interventions: Drug: Bazedoxifene Acetate;   Other: Placebo
16 Completed Efficacy Study of Risedronate to Prevent Cancer Treatment-Induced Bone Loss in Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: risedronate;   Drug: Control
17 Active, not recruiting A Study of Pertuzumab in Addition to Chemotherapy and Herceptin (Trastuzumab) as Adjuvant Therapy in Patients With HER2-Positive Primary Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Chemotherapy;   Drug: pertuzumab;   Drug: placebo;   Drug: trastuzumab [Herceptin]
18 Active, not recruiting Chronic Plaque Psoriasis (Ps) Registry
Condition: Chronic Plaque Psoriasis
19 Terminated GALLEX 6: Study to Evaluate the Safety and Tolerability of Tesaglitazar in Patients With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Tesaglitazar;   Drug: Pioglitazone
20 Completed LAPLACE-TIMI 57: LDL-C Assessment Wtih PCSK9 monoclonaL Antibody Inhibition Combined With Statin thErapy
Condition: Hyperlipidemia
Interventions: Biological: evolocumab (AMG 145);   Other: PLACEBO

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years